GLP-1 Side Effects: What to Expect in Your First 3 Months

Key takeaways:

• GI side effects (nausea, diarrhea, constipation) are the most common and usually improve after 4-8 weeks
• Slow dose titration significantly reduces side effect severity
• Most side effects are dose-dependent — they peak when you increase your dose
• Serious side effects are rare but include pancreatitis and gallbladder issues
• Talk to your doctor before adjusting doses or stopping medication

This is not medical advice. The information below is for educational purposes only. Always consult a qualified healthcare provider before starting any medication. See our full medical disclaimer.

The reality of GLP-1 side effects

If you are starting semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound), you will likely experience some side effects. The clinical trial data is clear: the majority of patients report at least one GI symptom during treatment.

But here is what the headlines miss — for most people, these side effects are temporary, manageable, and diminish significantly over time. The first few weeks are the hardest.

Week-by-week timeline

This timeline is based on published clinical trial data and commonly reported patient experiences. Individual timelines vary.

Weeks 1-2 (starting dose)

What to expect: Mild nausea, reduced appetite, possible bloating. Some people feel almost nothing at the starting dose.

The starting dose is intentionally low — semaglutide begins at 0.25mg/week, tirzepatide at 2.5mg/week. The goal is to let your body adjust before increasing.

Weeks 3-4 (first dose increase)

What to expect: This is usually when side effects peak. Nausea may increase, you might experience diarrhea or constipation, and food aversions can start. Some people report feeling "off" for 2-3 days after each injection.

This is normal. Your GLP-1 receptors are adjusting to the medication. The side effects are a sign the drug is working — it is slowing your gastric emptying and signaling your brain to reduce appetite.

Weeks 5-8 (adjustment period)

What to expect: Side effects typically begin to stabilize. Your body has adjusted to the current dose. Nausea decreases. Appetite regulation becomes more consistent.

If you increase your dose during this period, expect a temporary return of GI symptoms for a few days.

Months 2-3 (maintenance)

What to expect: Most GI side effects have resolved or become very mild. The medication's appetite-suppressing effects continue. If you are still experiencing significant nausea at this point, talk to your doctor about dose adjustment.

Common side effects by the numbers

Data from the STEP 1 (semaglutide 2.4mg) and SURMOUNT-1 (tirzepatide) clinical trials:

Side Effect	Semaglutide	Tirzepatide	When It Peaks
Nausea	44%	31%	Dose increases
Diarrhea	30%	23%	Weeks 2-6
Vomiting	24%	13%	Dose increases
Constipation	24%	12%	Weeks 1-4
Abdominal pain	20%	14%	Weeks 2-4
Headache	14%	13%	Weeks 1-2
Fatigue	11%	9%	Weeks 1-4

Sources: STEP 1 (PMID: 33567185), SURMOUNT-1 (PMID: 35658024)

How to manage nausea

Nausea is the most reported side effect and the one that causes the most people to consider stopping. These strategies are commonly recommended by physicians:

Eat smaller meals. Your stomach is emptying slower now. Large meals will sit longer and make nausea worse. Eat 4-5 small meals instead of 2-3 large ones.

Avoid greasy and fried foods. High-fat foods are harder to digest with slowed gastric emptying. Lean proteins, vegetables, and light carbs tend to be better tolerated.

Stay hydrated. Dehydration worsens nausea. Sip water throughout the day. Some people find ginger tea or peppermint tea helpful.

Time your injection wisely. Some people inject at bedtime to sleep through the worst nausea. Others prefer morning so they can manage symptoms throughout the day. Experiment to find what works.

Do not skip the titration schedule. The slow dose increase exists specifically to minimize side effects. Jumping to higher doses faster will make nausea significantly worse.

Serious side effects (rare but important)

While most GLP-1 side effects are GI-related and temporary, some are serious and require medical attention.

Pancreatitis. Reported in less than 1% of patients. Symptoms include severe abdominal pain radiating to the back, nausea, and vomiting. If you experience sudden severe abdominal pain, seek medical care immediately.

Gallbladder disease. GLP-1 medications are associated with an increased risk of gallstones and cholecystitis. Rapid weight loss (regardless of method) increases gallbladder risk. Symptoms include right upper abdominal pain, especially after meals.

Thyroid concerns. Both semaglutide and tirzepatide carry a boxed warning for thyroid C-cell tumors based on animal studies. This has not been confirmed in humans, but patients with a personal or family history of medullary thyroid carcinoma should not use these medications.

Hypoglycemia. Uncommon when used alone but possible when combined with insulin or sulfonylureas. Symptoms include shakiness, sweating, confusion, and rapid heartbeat.

When to call your doctor

Contact your healthcare provider if you experience:

• Severe or persistent nausea/vomiting lasting more than 48 hours
• Severe abdominal pain (could indicate pancreatitis)
• Signs of an allergic reaction (rash, swelling, difficulty breathing)
• Symptoms of hypoglycemia
• Depression or suicidal thoughts (rare reports under investigation)
• Any symptom that concerns you

My experience

In my experience — and this is purely anecdotal — the nausea was real but manageable. The worst days were the 2-3 days after each dose increase. Eating smaller meals and staying hydrated made the biggest difference. By month 2, the nausea was barely noticeable.

The appetite suppression, on the other hand, was dramatic. Food just stopped being the center of my day. That part was welcome.

FAQ

How long do GLP-1 side effects last?

Most GLP-1 side effects, particularly nausea and GI symptoms, improve significantly within 4-8 weeks of starting treatment or after each dose increase. The starting dose is intentionally low to allow your body to adjust. Side effects are typically worst during dose titration and stabilize once you reach your maintenance dose.

Does everyone get nausea on semaglutide?

No. While nausea is the most commonly reported side effect (44% in the STEP 1 trial at 2.4mg), that means over half of participants did not experience clinically significant nausea. Starting at a low dose and titrating slowly reduces your risk. Many people report only mild, transient nausea.

Can you take Zofran for GLP-1 nausea?

Some doctors prescribe ondansetron (Zofran) for patients with severe GLP-1-related nausea. This should only be done under medical supervision. Most physicians recommend lifestyle modifications first — smaller meals, avoiding fatty foods, proper hydration — before adding anti-nausea medication.

Do GLP-1 side effects mean the medication is working?

Not necessarily. Side effects indicate your body is responding to the medication, but the absence of side effects does not mean it is not working. The therapeutic effect (appetite reduction and metabolic improvement) can occur with or without noticeable GI symptoms.

Bottom line

GLP-1 side effects are real but usually temporary. The first 4-8 weeks are the hardest, particularly around dose increases. For most people, the side effects diminish to mild or absent levels by month 2-3.

The key is patience, proper dose titration, and working with your doctor to find the right dose that balances benefits and tolerability. Do not increase your dose faster than prescribed, and do not suffer in silence — your doctor can help manage difficult symptoms.

---

This article is for educational purposes only and is not medical advice. Always consult a qualified healthcare provider before starting, changing, or stopping any medication. See our full medical disclaimer.

Sources

1. Wilding JPH, et al. STEP 1: Semaglutide 2.4mg for weight management (NEJM, 2021; PMID: 33567185)
2. Jastreboff AM, et al. SURMOUNT-1: Tirzepatide for weight management (NEJM, 2022; PMID: 35658024)
3. FDA Prescribing Information — Wegovy (semaglutide injection 2.4mg)
4. FDA Prescribing Information — Zepbound (tirzepatide injection)